FDA approves first gene therapy for Sanfilippo syndrome, a rare childhood neurodegenerative disease
The FDA approved Ultragenyx’s gene therapy Fayuvi as the first treatment for Sanfilippo syndrome type A, a rare pediatric neurodegenerative disease, with price not disclosed.